Alphatec Holdings, Inc. (ATEC) News
Follow Alphatec Holdings, Inc. (ATEC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 13 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Alphatec Q3 Revenue Misses Expectations on Lower Biologics Attachment
EQUITY | Oct 29, 2026, 08:21 PM UTC
M
Alphatec Reports Q3 Revenue of $221.2M, Below FactSet Estimate
Alphatec Holdings reported Q3 revenue of $221.2 million, versus a FactSet estimate of $225.2 million.
EQUITY | Oct 29, 2026, 08:20 PM UTC
M
Alphatec Holdings Reports Third-Quarter 2026 Financial Results
Alphatec Holdings announced financial results for the quarter ended September 30, 2026.
EQUITY | Oct 29, 2026, 08:06 PM UTC
L
ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy
Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced that Thomas "Tommy" Carls has joined the company as Exe
NEWS | Sep 23, 2026, 08:35 PM UTC
L
ATEC: Strong volume growth, innovation, and margin gains support robust long-term financial targets
Procedural volumes and surgeon adoption remain strong, supporting high revenue growth and robust financial guidance through 2027. Product innovation, especially with Valence and EOS Insight, is driving clinical different
EARNINGS | Sep 09, 2026, 09:04 PM UTC
L
ATEC says procedural volumes and surgeon adoption drive strong growth
Alphatec says procedural volumes and surgeon adoption are driving strong growth, and that it has reaffirmed guidance for revenue, EBITDA and free cash flow. It cites product innovation in Valence and EOS Insight and the
EARNINGS | Sep 09, 2026, 08:38 PM UTC
L
ATEC Initiate with a Buy, GMED initiate with a Neutral @ UBS
ATEC Initiate with a Buy, GMED initiate with a Neutral @ UBS
EQUITY | Jul 28, 2026, 11:50 AM UTC
L
ATEC Initiated Buy W/$15.00 PT at UBS
ATEC Initiated Buy W/$15.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: O
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: OUTPERFORM @ Wedbush CRWD: BUY @ Loop FTH: OUTPERFORM @ Opp HRB: EQUAL WEIGHT @ S
EQUITY | Jul 28, 2026, 11:11 AM UTC
L
ATEC Initiated Overweight W/$15.00 PT at Stephens
ATEC Initiated Overweight W/$15.00 PT at Stephens
EQUITY | Jul 23, 2026, 11:55 AM UTC
L
ATEC new Overweight W/ $15 PT @ Stephens
ATEC new Overweight W/ $15 PT @ Stephens
EQUITY | Jul 23, 2026, 10:52 AM UTC
L
Alphatec initiated with bullish view at Stephens, here's why
Alphatec initiated with bullish view at Stephens, here's why
EQUITY | Jul 23, 2026, 09:36 AM UTC
H
Alphatec price target lowered to $13 from $16 at Stifel
Stifel lowered the firm's price target on Alphatec to $13 from $16 and keeps a Buy rating on the shares. Concerns over a potential 2026 Surgical revenue guidance cut remain elevated due to difficult comparisons and slowi
EARNINGS | Jul 08, 2026, 11:04 AM UTC